AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The positive benefit-risk profile of vericiguat in its approved indication in patients with HFrEF following a recent heart failure event based on the pivotal Phase III VICTORIA trial remains unchanged
Subscribe To Our Newsletter & Stay Updated